known that LSIL persists in 32% and progresses to carcinoma in situ (CIS) in 11% [4] . The HPV test is helpful in making decisions in cervical cytology. It is known that LSILs are related to low risk HPV types 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81 and HSILs and cervical cancers are related to high risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73 and 82. But some cervical intraepithelial neoplasia 2 (CIN 2) and 3 lesions develop without a preexisting CIN 1 [5, 6] . And HPVs are positive in CIN 1 about 85% [7, 8] . Some CIN 1s and almost all CIN 2 and 3 lesions are associated with monoclonal "high-risk" HPV types [5, 9] . For clinical convenience, cytological LSIL should be proven as pathological LSIL and cytological HSIL should be proven as pathological HSIL. But we could not agree to utilize such a rule in the clinic. The results of LSILs and HSILs in cytology are not always pathologic LSILs and HSILs. In cytological HSILs, the next step is simple. Cone biopsies always follow the cytologic HSILs. In cytological LSIL, it is necessary to make a decision between the cone biopsy or the follow-up. With the viewpoint that guidance is necessary in LSIL, HPV testing is one of the best choices for gynecologists before colposcopic consultation. A repeat pap follow up and immediate colposcopy are recommended as alternatives, if available [10] . We retrospectively reviewed the clinical characteristics of 200 cone biopsies and compared the results of cytological LSILs according to the HPV test fi ndings. The 40s and 50s are common ages for cone biopsy with cervical intraepithelial lesions. Cervical cancers were prevalent in the 30s-50s. LSIL, low grade squamous intraepithelial lesion; HSIL, high grade squamous intraepithelial lesion; cancer, cervical cancer.
Materials and Methods
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Chi-square and student-t tests were used in analysis. Results with P-value less than 0.05 were regarded as statistically signifi cant.
Results
Age and pathologic distribution (Table 1, Fig. 1)
The distribution of pathologic fi ndings is shown according to age (Table 1 , Fig. 1 ). The most frequent patient age for cone biopsies was in their 40s. The most frequent age for cancer patients was in their 30s. HSILs were most frequent in the 40s age group. LSILs were most frequent in 40s. Fig. 3 
Cone biopsy results and high risk type (HRT) HPV positivity (
)
In the LSIL patients, HRT-HPV positive patients were 16/20 (80%) and one LRT-HPV positive patient was 1/20 (5%). This means that 75% of LSIL patients have HRT-HPV in their lesions. A further indication is that 75% of LSIL may develop into HSIL or cancer. Low risk HPV was only found in LSIL. (Fig. 4) Among the LSIL patients CIN 1 were 16/26 (61.5%), CIN 2 were 2/26 (7.7%), CIN3 were 5/26 (19.2%), CIS was 1/26 (3.8%), severe than CIN2 were 8/26 (30.8%) and chronic cervicitis were 2 patients (7.7%). The concordance rate between cytology and pathology in LSIL was 61.5%. (Fig. 5A) .
Pathologic results in cytological LSILs
HRT-HPV in cytologic LSIL
In HRT-HPV positive cytologic LSIL 16 patients, 6/16 (37.5%) were more severe than HSIL upon pathologic diagnoses. The HSIL incidence was higher than the HRT-HPV negative group 2/10 (20%) and overall 8/26 (30.8%), but the rate of incidence has no statistical signifi cance in our study (P=0.42) (Fig. 5B) .
Discussion
In the management of cervical intraepithelial lesions, HPV tests are the preferred method of clinical aid. In cytological LSIL patients, we can do colposcopy directed punch biopsy and an HPV test in order to confi rm diagnosis and clinical guidance. In Anyang city, cone biopsies are commonly performed under the diagnosis of HSIL from the ages of 30-40 years. In ALTS, 83% of the women of the LSIL group were positive for high-risk type HPVs [11] . HRT-HPV prevalence was similar in pathological LSILs (80%) and HSILs (81.6%) patients in our study (Table 3 ). The prevalence The life of LSIL is not as serious. 90% of adolescent LSIL will spontaneously regress (< 21 years of age) [12, 13] . The HSIL rate is lower in post-menopause cytological LSIL women and they can be managed in the same way as ASC-US management in postmenopause [14, 15] . 90% of high risk HPV positive cytological LSIL patients spontaneously regress within 24 months [16] . 70% of LSIL with high risk HPV infected patients were spontaneously cleared of their infections [17] . Therefore, surgical treatment of LSIL is usually not preferred. However, it is necessary for pathological LSIL patients whose history was preceded by cytological HSIL or atypical glandular cells to undergo diagnostic excision biopsies or 6 month interval follow ups of colposcopy and cytology [10] . HRT HPV negative LSILs and low risk type HPV positive LSILs were found to be pathologically benign, as we expected. And a trend appears to exist in that high risk HPV positive cytological LSIL patients have increased rates of pathologically HSIL and cancer. It is not such a small portion as to be ignored and reaches approximately 30% [17] . Although our study has limited statistical infl uence, further research in HRT HPV positive LSIL patients would seem to be required. Cytological LSIL women with high risk type HPV should be managed cautiously, with cytology and colposcopy, and by at least a 6 month interval follow-up. Histologic diagnosis by punch biopsy or excision is also recommended in HRT HPV positive LSILs. A large scale study in LSIL patients would seem to be mandated as being necessary in relation to high risk type HPVs.
